Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival
Yumiko Ota, Daisuke Takahari, Takeshi Suzuki, Hiroki Osumi, Izuma Nakayama, Akira Oki, Takeru Wakatsuki, Takashi Ichimura, Mariko Ogura, Eiji Shinozaki, Mitsukuni Suenaga, Keisho Chìn, Kensei Yamaguchi
Topics & Concepts
NivolumabCancerMedicineNeutrophil to lymphocyte ratioLymphocyteOncologyInternal medicineImmunologyImmunotherapyInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersGastric Cancer Management and Outcomes